Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?

Back

EHRA Premium Access

Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?

Session: Stroke prevention with and without LAAO

Topic: Stroke Prevention

Speaker: Doctor S. Van Laer (Edegem, BE)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Sven Van Laer

Antwerp University Hospital, Edegem (Belgium)

0 follower

7 more presentations in this session

Left atrial appendage closure in the presence of thrombus: incidence, technique and outcomes

Speaker: Doctor A. Fontenla Cerezuela (Pozuelo de Alarcon, Madrid, ES)

Periprocedural safety and efficacy after left atrial appendage closure in a large UK tertiary centre: 10-year experience

Speaker: Doctor A. Briosa E Gala (Oxford, GB)

Is transesophageal echocardiogram mandatory for patients undergoing ablation for right atrial flutter with uninterrupted anticoagulants? A prospective single registry.

Speaker: Doctor A. Suzat (Saint Priest En Jarez, FR)

Short dual antiplatelet strategy following left atrial appendage closure with Watchman and Watchman FLX: 1-year outcomes

Speaker: Doctor A. Briosa E Gala (Oxford, GB)

Socioeconomic trends in oral anticoagulation therapy for atrial fibrillation patients with low risk of stroke

Speaker: Doctor E. Danielsen Lunde (Aalborg, DK)

Access the full session

Stroke prevention with and without LAAO

Speakers: Doctor S. Van Laer, Doctor A. Fontenla Cerezuela, Doctor A. Briosa E Gala, Doctor A. Suzat, Doctor A. Briosa E Gala...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources